Release Date: 24/04/18 09:46 Summary: Ensurance to undertake Share Placement and Entitlement Offer Price Sensitive: Yes Download Document 133.58KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status